Analysts’ View: Incyte (INCY), InSteel Industries (IIIN), Duluth Holdings Inc. (DLTH)

Investment Analysts at Gabelli & Co upgrade Incyte Corporation (NASDAQ:INCY) shares from Hold to Buy rating with a price target of $105.

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States.


Brokerage Firm Sidoti upgraded InSteel Industries, Inc. (NASDAQ:IIIN) shares from Neutral to Buy rating with a price target of $25.

Insteel Industries, Inc., together with its subsidiaries, manufactures and markets steel wire reinforcing products for concrete construction applications.


Duluth Holdings Inc. (NASDAQ:DLTH) shares were upgraded by analysts at DA Davidson from Hold to Buy rating.

Duluth Holdings Inc. sells casual wear, workwear, and accessories for men and women under the Duluth Trading brand in the United States.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at